University of Miami gifts ibogaine application to Trump admin

The University of Miami has reportedly transferred its original 1994 ibogaine application to the Trump administration. This move could potentially accelerate the use of psychedelics in treating veterans, according to a report on NewsBreak.

What the announcement entails

The announcement, made by former President Donald Trump, suggests that the University of Miami's decision to hand over its ibogaine application could significantly speed up the process of utilizing psychedelics for therapeutic purposes. This development is particularly relevant for veterans suffering from conditions such as opioid addiction and PTSD.

Potential impact on psychedelic research

The gifted application is expected to facilitate research into ibogaine, a psychoactive substance that has shown promise in treating opioid use disorder. Advocates like Joe Rogan have highlighted ibogaine's potential, claiming that a single dose can help over 80% of individuals overcome addiction, with two doses increasing the success rate to over 90%.

Why it matters

The transfer of the ibogaine application could be a pivotal step in advancing psychedelic research and treatment options for veterans. With millions of people in the U.S. affected by opioid addiction, new therapeutic avenues are urgently needed. The use of ibogaine, if proven effective, could offer a transformative solution for those struggling with addiction and other mental health issues.

This development underscores the growing interest in psychedelic substances as potential treatments for a range of psychological conditions, particularly among veterans who may benefit from alternative therapies.

For further details, read the original report on NewsBreak.